Table of contents

01 - Pre-Meeting Briefing prepared by NICE

02 - Submission from the company - Eli Lilly and Company

03 - NICE request to the company for clarification on their submission

04 - Company clarification response

05 - Consultee submission - NCRI/RCP/ACP

06 - Consultee submission - Royal College of Pathologists

07 - Clinical expert personal statement - Starling

08 - Clinical expert personal statement - Mansoor

09 - Evidence Review Group report prepared by Kleijnen Systematic Reviews

10 - Evidence Review Group Addendum prepared by Kleijnen Systematic Reviews

11 - Company factual accuracy check of Evidence Review Group report

12 - Erratum to the Evidence Review Group report prepared by Kleijnen Systematic Reviews